Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Microorganisms in Agriculture and Food industry

Microorganisms in Agriculture and Food industry

Microorganisms play a crucial role in agriculture and the food industry, contributing to soil fertility, crop protection, and food production. Their functions range from nitrogen fixation and biopesticide production to fermentation and food preservation, making them indispensable to sustainable farming and food safety.Role in AgricultureNitrogen-fixing bacteria, such as Rhizobium (symbiotic) and Azotobacter (free-living), convert atmospheric nitrogen into ammonia through biological nitrogen...

Therapeutic Index

Therapeutic Index

The therapeutic index of a drug is a key parameter in pharmacology that quantifies the relative safety of a drug by calculating the ratio between the dose that causes toxicity in half the population (50%) to the dose that proves to be effective for half the population (50%). It provides a spectrum of doses for a particular drug ranging from effective to potentially toxic. To illustrate, consider an anticoagulant agent like warfarin. It possesses a narrow window within its therapeutic index to...

Therapeutic Communication

Therapeutic Communication

Communication is a lifelong learning process. Through therapeutic communication, nurses can collect relevant assessment data, provide education and counseling, and interact during nursing interventions. Sending and receiving messages occur through verbal and nonverbal communication techniques and can happen separately or simultaneously.
Verbal communication depends on language or a prescribed way of using words so that people can share information effectively. The critical aspects of verbal...

Cholinergic Antagonists: Therapeutic Uses

Cholinergic Antagonists: Therapeutic Uses

Antimuscarinic drugs have various therapeutic applications by inhibiting parasympathetic stimulation in different systems. Here are the key therapeutic uses of antimuscarinics:
Respiratory Tract: Ipratropium, aclidinium, and tiotropium treat asthma, chronic bronchitis, and chronic obstructive pulmonary disease (COPD). They protect against bronchoconstriction caused by irritants like cigarette smoke, sulfur dioxide, and ozone. They also help reduce nasopharyngeal...

Microorganisms in Medicine and Therapeutics

Microorganisms in Medicine and Therapeutics

Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.

Adrenergic Agonists: Therapeutic Uses

Adrenergic Agonists: Therapeutic Uses

Adrenergic agonists have diverse therapeutic uses across various medical conditions and emergencies.
Emergency and Intensive Care Unit (ICU) applications: Pressor agents increase blood pressure, heart rate, and contractility in shock and organ failure situations. Dopamine can induce vasodilation and stimulate adrenoceptors. Endogenous catecholamines are effective in treating cardiogenic shock. α2-agonists like clonidine can reverse anesthesia-induced hypertension.
Allergies and...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

May 2025 therapeutic delivery: industry update.

Therapeutic delivery·2025

Same author

Industry update: the latest developments in the field of therapeutic delivery, January 2025.

Therapeutic delivery·2025

Same author

Industry Update, May 2024.

Therapeutic delivery·2025

Same author

September 2024 therapeutic delivery: industry update.

Therapeutic delivery·2024

Same author

Industry News October 2020.

Therapeutic delivery·2021

Same author

February 2020 therapeutic delivery update.

Therapeutic delivery·2020

Search research articles

Related Experiment Video

Updated: Feb 1, 2026

Delivery of Therapeutic siRNA to the CNS Using Cationic and Anionic Liposomes

Delivery of Therapeutic siRNA to the CNS Using Cationic and Anionic Liposomes

Published on: July 23, 2016

November 2025 therapeutic delivery: industry update.

Elaine Harris¹

¹School of Chemical and BioPharmaceutical Sciences, Technological University Dublin, Dublin, Ireland.

Therapeutic Delivery

|January 31, 2026

Summary

This summary is machine-generated.

November 2025 highlighted advancements in drug delivery technologies with new product approvals and strategic acquisitions. Key developments include Johnson & Johnson

Keywords:

Transdermal bioerodible drug delivery enhanced bioavailability ocular delivery

More Related Videos

Intranasal Delivery of Therapeutic Stem Cells to Glioblastoma in a Mouse Model

Intranasal Delivery of Therapeutic Stem Cells to Glioblastoma in a Mouse Model

Published on: June 4, 2017

Delivery of Cardioactive Therapeutics in a Porcine Myocardial Infarction Model

Delivery of Cardioactive Therapeutics in a Porcine Myocardial Infarction Model

Published on: February 10, 2023

Related Experiment Videos

Last Updated: Feb 1, 2026

Delivery of Therapeutic siRNA to the CNS Using Cationic and Anionic Liposomes

Delivery of Therapeutic siRNA to the CNS Using Cationic and Anionic Liposomes

Published on: July 23, 2016

Intranasal Delivery of Therapeutic Stem Cells to Glioblastoma in a Mouse Model

Intranasal Delivery of Therapeutic Stem Cells to Glioblastoma in a Mouse Model

Published on: June 4, 2017

Delivery of Cardioactive Therapeutics in a Porcine Myocardial Infarction Model

Delivery of Cardioactive Therapeutics in a Porcine Myocardial Infarction Model

Published on: February 10, 2023

Area of Science:

Biotechnology and Pharmaceutical Sciences
Drug Delivery Systems

Background:

The pharmaceutical landscape in November 2025 was marked by significant product approvals and strategic business developments.
Advancements in drug delivery technologies are crucial for enhancing therapeutic efficacy and patient compliance.

Purpose of the Study:

To summarize key product approvals utilizing novel drug delivery technologies.
To highlight significant acquisitions and collaborations in the biotechnology sector.
To report on positive clinical trial data releases.

Main Methods:

Review of product approvals and regulatory filings.
Analysis of company announcements regarding mergers, acquisitions, and collaborations.
Monitoring of clinical trial data disclosures.

Main Results:

Approval of Johnson and Johnson's DARZALEX FASPRO (with Halozyme's ENHAZE), Merck's KEYTRUDA QLEX, and Regeneron's EYLEA HD, showcasing diverse delivery technologies.
Halozyme acquired Elektrofi, gaining access to Hypercon microparticulate technology, and partnered with Merus for a subcutaneous formulation.
Positive clinical trial data was reported by EyePoint, Tiziana, Nasus, and Tonix.

Conclusions:

November 2025 demonstrated significant innovation in drug delivery and strategic consolidation within the pharmaceutical industry.
The reported clinical trial successes indicate promising therapeutic developments across multiple companies.